This trial tests two inhalers for asthma in patients whose condition isn't well-controlled with current treatments. One inhaler combines two medications to reduce inflammation and open airways, while the other only reduces inflammation. The combination of budesonide and formoterol in a single inhaler has been shown to improve asthma control by providing both maintenance and reliever therapy.